Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Teva False Claims Settlement Stems From Kickbacks To Single Doctor

This article was originally published in The Pink Sheet Daily

Executive Summary

Teva reaches $27.6 million settlement with Department of Justice and the state of Illinois over prescriptions for generic clozapine; deal comes as Ivax subsidiary is in final year of five-year corporate integrity agreement.

You may also be interested in...



Pharma Deals With The DOJ

A look at the settlement agreements pharma companies have struck with the Department of Justice in the last three years; the size of the deals has declined dramatically since 2012.

Does Former Warner Chilcott Exec’s Arrest Portend More Prosecutions?

Carl Reichel indicted for conspiring to pay kickbacks to physicians while firm pleads guilty to health care fraud; former DOJ attorneys provide insights on case.

Under DOJ’s Microscope: Teva Is Latest Company To Face Government Probe

AstraZeneca, Merck, Novartis and Sanofi are also under investigation for potential health care fraud.

Related Content

Topics

Related Companies

Latest News
UsernamePublicRestriction

Register

PS076943

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel